ARUNDATHI NARAYANAPPA: Open Payments
NPI 1679520522 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,508 in 64 payments from 13 companies in 2025. Trend: 2023 $2,447 · 2024 $1,518 · 2025 $2,508
Food & beverage: $2,508
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 21 | $480 |
| Kowa Pharmaceuticals America, Inc. | 18 | $392 |
| Galderma Laboratories, L.P. | 10 | $309 |
| LEO Pharma Inc. | 2 | $288 |
| REVANCE THERAPEUTICS, INC. | 2 | $251 |
| Lilly USA, LLC | 3 | $162 |
| Incyte Corporation | 2 | $158 |
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| UCB, Inc. | 1 | $125 |
| Arcutis Biotherapeutics, Inc. | 1 | $88 |
Products named: CIBINQO, ZORYVE, DAXXIFY, NEMLUVIO, Opzelura, ANZUPGO, ADBRY, DUPIXENT.
Industry payments across AZ — which companies pay providers there.
